.launch-header{position:relative!important}.launch-desktop-nav button,.launch-mobile-toggle,.experience-region-trigger{display:none!important}.experience-noscript-nav{display:flex;flex-wrap:wrap;justify-content:center;gap:16px;padding:16px;background:#f8fafc;font-size:13px}.experience-noscript-nav a{min-height:44px;display:inline-flex;align-items:center}Prognia Ward Suture Osler Medical library Learning resources Pricing Crowdfunding Founders Wall English Nederlands Español Français Deutsch

Loading your page…

Le némolizumab (Nemluvio®), nouvel anticorps monoclonal en dermatologie | Prognia Clinical Articles

Le némolizumab (Nemluvio®), nouvel anticorps monoclonal en dermatologie

Abstract / Summary